Recovery · Reference
TB-500 for Men: What the Research Has Looked At, and What It Is Not
This page covers what TB-500 is, what research has and has not looked at, the questions men most often ask (testosterone, TRT, muscle, hair, fertility, sport), what a physician rules out first in men over 40, and how Pepti supplies it. The general reference is what is TB-500, and the evidence benefit by benefit is in TB-500 benefits.
Treatments mentioned
TB-500 has not been studied in men specifically: its research is animal and cell work on thymosin beta-4, the larger protein it is a fragment of, plus one 2026 rat Achilles tendon study of TB-500 itself, and the FDA found no human study of TB-500 by any route. For men, the useful points are what it is not and where it sits. It is not a hormone, a steroid or a testosterone booster, and nothing in its research describes it moving testosterone or any hormone axis, which is why it is a common addition for a shoulder, knee or Achilles that limits training. It is prohibited at all times in tested sport, and it is a compounded prescription injection that is not FDA approved.
This page covers what TB-500 is, what research has and has not looked at, the questions men most often ask (testosterone, TRT, muscle, hair, fertility, sport), what a physician rules out first in men over 40, and how Pepti supplies it. The general reference is what is TB-500, and the evidence benefit by benefit is in TB-500 benefits.
TB-500 for Men
The short answer
| Question | What the live research shows | Strength of evidence |
|---|---|---|
| Has TB-500 been studied in men specifically? | No; no study reports sex-specific findings, and no human study of TB-500 exists | None |
| Tendon repair | One 2026 rat Achilles study (Joint Diseases and Related Surgery) | Animal only, eight animals per group |
| Skin wound healing | Rats and mice, mostly the full protein (1999, 2003) | Animal; human gel trials used the full protein |
| Does it raise testosterone? | Not described as acting on testosterone or any hormone axis | Not a testosterone booster |
| Does it build muscle? | Not an anabolic; no study describes added muscle or strength | Not a performance drug |
| Hair | Full-protein work in rat and mouse follicles (FASEB Journal, 2004) | Animal only; no human trial |
| Fertility | No developmental or reproductive studies of TB-500 | No data |
| Tested sport | Named under S2.3 of the 2026 WADA Prohibited List, prohibited at all times | Clear exclusion |
The honest summary: a broad animal literature on the parent protein, a single rat tendon study of the fragment, and nothing that makes TB-500 a men's hormone product.
TB-500 for Men
What TB-500 is, in one paragraph
Thymosin beta-4 is one of the most abundant small proteins inside human cells, where it holds actin, the protein that lets a cell move, in reserve. Platelets release it at injury sites. TB-500 is a synthetic seven-amino-acid fragment of that protein, Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln (LKKTETQ), the region that binds actin. Most published work, and every human trial, used the full 43-amino-acid protein, and the FDA's July 2026 briefing put it directly: "thymosin beta-4 and TB-500 are not the same substance." TB-500 is not a hormone and not a steroid. It does not bind an androgen receptor, is not described as suppressing your own hormone production, and nothing in the research describes a painkilling mechanism.
TB-500 for Men
What research has looked at
Tendon in rats, the one study of the fragment
This is the work most relevant to the injuries men usually ask about. A 2026 paper in Joint Diseases and Related Surgery randomized 32 rats with a repaired Achilles tendon to control, BPC-157, TB-500 or both for four weeks. Load to failure was higher in both peptide groups than in controls, reaching statistical significance for TB-500, and the combination did no better than either peptide alone.
What it shows. That TB-500 itself did something measurable in one rat tendon model.
What it does not show. That it happens in a person, how large an effect would be, or how long it would take. It was one exploratory study with eight animals per group, intraperitoneal rather than subcutaneous dosing, a four-week endpoint and no dose-ranging. There are no human studies of TB-500 for any tendon, ligament or muscle injury.
Skin, blood vessels and the heart, in animals
A 1999 paper in the Journal of Investigative Dermatology reported thymosin beta-4 speeding closure of skin wounds in rats, and a 2003 paper in Wound Repair and Regeneration extended that to diabetic and aged mice, testing the LKKTETQ fragment alongside the full protein. A 2004 paper in Mechanisms of Ageing and Development described new blood vessel growth, and papers in Nature in 2004 and 2007 described heart repair after induced heart attacks in mice. All of that is animal work, and most of it is the full protein.
The human studies
Full-length thymosin beta-4 has a 2010 randomized, placebo-controlled intravenous safety study in healthy volunteers, phase 2 trials of a topical gel in skin ulcers, and a 2015 phase 2 trial of eye drops in severe dry eye (Cornea). None used the TB-500 fragment, none used subcutaneous injection, none looked at a tendon, muscle or joint, and none reported results separately for men.
TB-500 for Men
What changes for men
It is not a testosterone booster
TB-500 is studied around cell migration and tissue repair. It is not described as moving testosterone, estradiol or any other hormone, and it is not on the list of things that have been looked at for low testosterone. If low testosterone is the question, peptides for testosterone covers what has and has not been studied.
It is not an anabolic
TB-500 does not add muscle or strength directly, and nothing in its research describes it as a performance enhancer. The animal work is about repair after injury, measured in injured animals, not about building muscle in healthy ones. Its place in a man's plan is the joint or tendon that is capping training, not the training itself.
Alongside testosterone therapy
BPC-157 with TB-500 is one of the more common additions for men already on TRT, because the limiting factor is often a shoulder or an ankle rather than a hormone level. The live pages describe the repair peptides as a different conversation that does not touch the markers TRT is monitored by. There is no randomized trial of TB-500 given alongside testosterone replacement and no established interaction list, because those trials have not been run. List your testosterone prescription, dose and whoever manages it on your intake. The wider picture is in can you take peptides with testosterone.
Hair
The hair claim comes from the full protein: a 2004 paper in the FASEB Journal reported thymosin beta-4 increasing hair growth in rats and mice and acting on follicle stem cells, and a 2007 paper extended this across rodent models. There is no human hair trial of thymosin beta-4 or TB-500, so it is not a hair-loss treatment for men. See peptides for hair growth.
Fertility
The FDA's July 2026 review identified no nonclinical toxicity, developmental, reproductive or carcinogenicity studies of TB-500. No study has looked at sperm or male fertility in either direction. If conception is a goal in any timeframe you can name, raise it with your physician before starting. Do peptides affect fertility covers the conversation.
Tested sport
TB-500 is prohibited at all times under S2.3 of the 2026 WADA Prohibited List as a thymosin beta-4 derivative. A prescription does not change that. If you are tested by any body, tell your physician before starting. See peptides for athletes.
TB-500 for Men
Men over 40: what a physician rules out first
Tendons and ligaments heal slowly, and the shoulder from a decade ago can still be there. But the complaints men bring with an old injury, low energy, poor recovery and a soft middle, often have causes no vial addresses.
| What it is | How it shows up | Why it comes first |
|---|---|---|
| A structural injury | Night pain, numbness, weakness, a locking joint | Needs imaging; a complete rupture or displaced fracture is a surgical question no peptide changes |
| Tendinopathy that has not been loaded properly | A tendon that flares with use | Progressive loading under a physical therapist has human trial evidence that TB-500 does not |
| Obstructive sleep apnoea | Exhaustion, low testosterone, poor recovery | Lowers testosterone and IGF-1 in proportion to severity |
| Genuinely low testosterone | Low desire, poor morning erections, lost muscle | A different treatment with its own monitoring |
| Alcohol intake | Fragmented sleep, low testosterone, central fat | A common reversible cause, and one rarely raised |
More on this is in peptides for men over 40.
TB-500 for Men
Safety and who should not take it
TB-500 is reported as well tolerated, but that rests on animal studies and prescriber experience rather than on human safety trials of the fragment. Nothing in the live research suggests the profile differs between men and women.
| What is reported or relevant | How often | What to do |
|---|---|---|
| Injection-site redness, itching, a small lump, tenderness | Common | Rotate sites; mention it at follow-up |
| Tiredness or a head-fog feeling in the first one to two weeks | Common | Report it; it usually settles |
| Light-headedness or a flushed feeling shortly after dosing | Uncommon | Report it to your care team |
| Transient joint or muscle ache | Uncommon | Report it |
| A site that is hot, spreading or worsening after 48 hours; a new lump; unexplained bleeding | Stop and call | Stop dosing and contact your physician the same day |
| Facial or throat swelling, widespread rash, difficulty breathing | Rare | Call 911 first, then tell your physician |
| Active or recent cancer | Before treatment | Its described mechanisms overlap with the ones tumors use; not prescribed |
| Blood thinners or autoimmune disease | Before treatment | Discuss with your physician first |
The FDA's central stated concern is immunogenicity, an immune reaction to aggregated peptide or impurities, which is an argument for a tested pharmacy preparation. The full detail is in is TB-500 safe.
TB-500 for Men
Where TB-500 stands with the FDA
TB-500 was placed in Category 2 of the FDA's 503A bulks list in 2023, over potential immunogenicity, and removed from it in April 2026. On 23 July 2026 the Pharmacy Compounding Advisory Committee voted 8 to 6, with one abstention, to recommend adding TB-500 to the 503A Bulks List, against the FDA staff's proposal; the FDA's final determination is pending. It remains legal to prescribe and compound against a valid prescription. Compounded medications, TB-500 included, are not FDA approved.
TB-500 for Men
How Pepti supplies TB-500
| Product | What is in it | Typical directions | Price |
|---|---|---|---|
| TB-500 | 5 mL vial, 1 mg/mL (5 mg TB-500) | 0.25 mL (25 units) subcutaneously Monday through Friday mornings; 0.25 mg per dose, 20 doses per vial | $209/mo |
| BPC-157 + TB-500 | 5 mL vial, 1 mg/mL of each (5 mg BPC-157, 5 mg TB-500) | 0.25 mL (25 units) Monday through Friday mornings; 0.25 mg of each per dose | $259/mo |
| REVIVE Blend | 50 mg GHK-Cu, 6 mg CJC-1295, 12 mg ipamorelin, 2 mg TB-500 in 5 mL | 0.25 mL (25 units) Monday through Friday nights at bedtime | $279/mo |
REVIVE adds growth-hormone-axis peptides, which bring their own considerations. The arithmetic for the vial is in TB-500 dosage, and the comparison with BPC-157 is in BPC-157 vs TB-500; the BPC-157 version of this page is BPC-157 for men. Your physician sets your directions after reviewing your intake, and they are printed on the vial.
Every price is all-in, covering medication, physician review, refill management and shipping, with no membership fee. Pepti is cash-pay and does not bill insurance. Twenty weekday doses is four weeks, so refills run every 28 days, one vial per fill. Vials arrive as ready-to-use multi-dose solutions with sterile syringes and alcohol prep pads, shipped refrigerated with ice packs.
TB-500 for Men
Where to get TB-500 prescribed
TB-500 cannot be bought legitimately without a prescription. "TB-500" is a common name rather than an official drug name, and the FDA reports encountering multiple salts and derivatives sold under that one label. See research peptides vs prescription peptides. The prescription route:
- Complete a free online intake covering the injury, any imaging, your medications (including any testosterone), whether you are drug tested, and what you want help with.
- A physician licensed in your state reviews it, usually within 24 hours.
- If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription. Lot test results are published at /quality/lab-results.
- It ships refrigerated with your directions printed on the vial.
- Your care team stays reachable for questions and side effects.
Step by step: how to get TB-500 prescribed online. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.
References
What this is based on.
References
- Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues · Trends Mol Med (2005) · PMID 16099219
- Malinda KM, Sidhu GS, Mani H et al.. Thymosin beta4 accelerates wound healing · J Invest Dermatol (1999) · PMID 10469335
- Malinda KM, Goldstein AL, Kleinman HK. Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells · FASEB J (1997) · PMID 9194528
- Philp D, Badamchian M, Scheremeta B et al.. Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice · Wound Repair Regen (2003) · PMID 12581423
- Philp D, Goldstein AL, Kleinman HK. Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development · Mech Ageing Dev (2004) · PMID 15037013
- Philp D, Scheremeta B, Sibliss K et al.. Thymosin beta4 promotes matrix metalloproteinase expression during wound repair · J Cell Physiol (2006) · PMID 16607611
- Smart N, Risebro CA, Melville AA et al.. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization · Nature (2007) · PMID 17108969
- Sosne G, Szliter EA, Barrett R et al.. Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury · Exp Eye Res (2002) · PMID 11950239
- Sosne G, Hafeez S, Greenberry AL 2nd et al.. Thymosin beta4 promotes human conjunctival epithelial cell migration · Curr Eye Res (2002) · PMID 12324865
- Sosne G, Xu L, Prach L et al.. Thymosin beta 4 stimulates laminin-5 production independent of TGF-beta · Exp Cell Res (2004) · PMID 14729067
- Sosne G, Qiu P, Christopherson PL et al.. Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway · Exp Eye Res (2007) · PMID 17254567
- Sosne G, Qiu P, Goldstein AL et al.. Biological activities of thymosin beta4 defined by active sites in short peptide sequences · FASEB J (2010) · PMID 20179146
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
TB-500 for Men, answered.
It has not been studied in men specifically, and TB-500 has no human study of any kind. Its research is animal and cell work on thymosin beta-4 and one 2026 rat tendon study of the fragment. For men it is most often prescribed for a tendon, ligament or old injury that limits training, on the strength of that animal work and prescriber experience.
No. It is not described as acting on testosterone or any hormone axis.
No. It is not an anabolic and does not add muscle or strength directly. The animal studies looked at repair after injury.
It is a common addition, usually with BPC-157, because it addresses a different problem from any hormone. There is no study of the combination, so list your testosterone prescription and whoever manages it on your intake.
Not on current evidence. The hair findings used the full thymosin beta-4 protein in rats and mice, and there is no human hair trial of either molecule.
No study has looked. The FDA found no developmental or reproductive studies of TB-500. Raise conception plans with your physician before starting.
No. It is a seven-amino-acid fragment of thymosin beta-4 that does not bind an androgen receptor.
Yes, at all times. The 2026 WADA Prohibited List names thymosin beta-4 and its derivatives, TB-500 included, under S2.3. A prescription does not create an exemption.
It is commonly prescribed for that, often with BPC-157. A physician first rules out a structural injury, sleep apnoea, low testosterone and other causes, and progressive loading under a physical therapist has human evidence that TB-500 does not.
The same as for anyone: mostly injection-site redness, itching or a small lump, and sometimes tiredness in the first week or two or a brief flushed or light-headed feeling. Facial or throat swelling or difficulty breathing after a dose needs 911.
At Pepti, TB-500 is $209 a month and BPC-157 + TB-500 is $259 a month, all-in, covering medication, physician review, refill management and shipping.
No. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.